Dr. Nathan Guerette Highlights Continued Advances in Female Pelvic Medicine
The Virginia urogynecologist continues to combine high-volume reconstructive surgery, clinical research, and medical technology development in the treatment of complex...
Pharmaceutical
Jaguar Health’s Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Mutation of the GUCY2C gene is the third IF-related congenital enteropathy, in addition to microvillus inclusion disease (MVID) and short...
Medical Care Technologies Inc. (OTCID:MDCE) Transitions From Selling AI Software to Also Providing AI Model Training Consulting
Company Adds Enterprise Consulting Services Alongside First $250,000 Software Agreement and Six-Figure Collectibles Partnership Activity MESA, AZ / ACCESS Newswire...
How To Prepare Your Household for Cold and Flu Season
NORTHAMPTON, MA / ACCESS Newswire / October 21, 2026 / CVS HealthOriginally published on CVS Health Company NewsroomKey pointsCold and...
Rapid Dose Therapeutics Ships QuickStrip(TM) Production Line to Callan JMB’s Texas cGMP Facility
Burlington, Ontario--(Newsfile Corp. - October 21, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a...
Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai
~President James Morrison met Middle East family offices as Ensysce advances CY200 and its severe pain pipeline~ SAN DIEGO, CA...
Valion Bio’s New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
Interim CEO Dean Zikria's initial review prioritizes Entolimod and pipeline advancement, commercialization of Velocity Bioworks, and strategic opportunities to maximize...
Omre NMN + Resveratrol Posts the Highest NMN Purity in Independent Testing, and 1,500+ Reviews Back It Up
Doctor-developed, over-99%-pure NMN with 500 mg of micronized resveratrol, tested twice by independent labs and rated 4.7 out of 5...
Vistin Pharma ASA: Invitation to Q3 2026 conference call
Oslo, Norway, 21 October 2026 Vistin Pharma ASA (VISTN) will release its third quarter and YTD 2026 results on Thursday...
Bioxodes BIOX-101 Phase 2a data show statistically significant reduction in perihematomal edema growth in intracerebral hemorrhage
First disclosure of new imaging analyses and one-year functional outcome were presented at the World Stroke Congress todayChange in normalized...
Avance Clinical to Meet European Biotechs at ESMO Congress 2026 and Appoints Wendy Hamon as Senior Vice President, Oncology Center of Excellence
Executive Medical Director Dr George Peoples to discuss oncology programs from preclinical through Phase II in Madrid Wendy Hamon Wendy...
First Patient Treated in the C-FLASH-01 ConformalFLASH® Clinical Trial
First Patient Treated in the C-FLASH-01 ConformalFLASH® Clinical Trial Louvain-la-Neuve, Belgium, October 21, 2026 – IBA (Ion Beam Applications S.A.,...
F2G and Shionogi Report Data from Global Phase 3 OASIS Study Evaluating Investigational Oral Olorofim Versus AmBisome® Followed by Standard of Care in Invasive Aspergillosis in Late-Breaking Oral Presentation at IDWeek 2026
Oral olorofim was non-inferior to AmBisome® followed by standard of care (AmBisome®+SOC), with Day 42 all-cause mortality of 23.8% for...
Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock
WATERTOWN, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on...
HUTCHMED Announces Closing of KRAS-EGFR-Antibody Conjugate Therapy License to GSK Outside China
HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Oct. 20, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”)...
Ascentage Pharma’s Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLL
ROCKVILLE, Md., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated...
Telix Reports Third Quarter 2026 Financial Performance
MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides a...
BioSyent to Present at Planet MicroCap Toronto
MISSISSAUGA, Ontario, Oct. 20, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it...
Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026
LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences...
Pulse Equity: The Healthcare Robots and Gix Internet Aims to Transform Critical Deliveries in Hospitals with AI-Powered Autonomous Systems
HONG KONG, Oct. 20, 2026 /PRNewswire/ -- GIX Internet Ltd. (NASDAQ: GIXI) (TASE: GIX) ("GIX" or the "Company") is an Israeli...